Summary & Overview
CPT 0821T: Concurrent In-Person Monitoring During Psychedelic Medication Therapy
CPT code 0821T designates an hourly service in which a second physician or other qualified healthcare professional (QHP) provides continuous, in-person monitoring and intervention concurrent with a primary clinician during psychedelic medication therapy. The code recognizes the need for an additional clinician to manage potential emotional and physiological events that may occur during these sessions and establishes a billing mechanism for that dedicated, hourly presence. Nationally, this code matters as psychedelic-assisted therapies expand in clinical settings and payers evaluate coverage and payment policies for multi-clinician care models.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how the code is defined, typical service settings and clinical rationale, and which payers are relevant to coverage discussions. The publication also summarizes expected benchmarking topics, potential policy considerations affecting adoption, and the clinical context for physician staffing during psychedelic medication sessions.
Data not available in the input for specific modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and service-line billing detail. The report focuses on the code definition, service implications, and payer landscape at a national level.
Billing Code Overview
CPT code 0821T describes a second physician or other qualified healthcare professional (QHP) who provides continuous, in-person monitoring and intervention concurrent with a first physician or QHP during a patient’s psychedelic medication therapy. This service is reported per hour and is intended to address potential emotional and physiological issues that can arise during the therapy.
Service Type: Concurrent in-person monitoring and intervention during psychedelic medication therapy
Typical Site of Service: Behavioral health or procedural setting where supervised psychedelic-assisted therapy is delivered, including inpatient or outpatient treatment areas staffed for continuous monitoring
Clinical & Coding Specifications
Clinical Context
A 34-year-old patient with treatment-resistant major depressive disorder undergoes a supervised psychedelic-assisted medication session in an outpatient behavioral health center. The treatment team includes a physician who administers the psychedelic medication and leads the therapeutic process, while a second qualified healthcare professional provides continuous, in-person monitoring and immediate intervention throughout the session due to potential emotional and physiological effects. The second clinician remains in the room for the entire hour-long monitoring period, observes vital signs and mental status, manages acute anxiety or agitation, provides grounding and safety measures, and coordinates emergency escalation to medical staff if needed. Typical workflow steps: intake and consent, baseline vitals and mental status, medication administration by the lead clinician, concurrent in-person monitoring billed per hour using 0821T, ongoing documentation of interventions and patient responses, post-session recovery and discharge instructions, and billing with appropriate modifiers for concurrent service, time units, and any unusual circumstances.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
62 | Two surgeons or co-surgeons | Use when two physicians of different specialties provide concurrent intra-procedural roles; applicable if two physicians equally share operative responsibilities during an invasive procedure associated with psychedelic therapy (rare). |